Patients are flocking to compounded weight-loss drugs, but are they safe
This, coupled with decreasing glutathione production as we age, leaves most of us deficient. The average American consumes only 35 milligrams of glutathione per day, when the daily intake is 250 milligrams
Tirzepatide has shown superior glycemic control compared to other GLP-1s, likely due to its dual action on GIP and GLP-1 receptors
FDA that claimed that Eli Lilly was only able to catch up with demand by the fall of 2024 due to the compounders efforts to supplement supply
There is no strong controlled-trial data showing that methionine, inositol, and choline injections produce clinically meaningful fat loss beyond what the accompanying diet, exercise, and supervision account for